That this House has considered premature deaths from heart and circulatory diseases.
I start with something I never thought that I would stand here discussing. As I shared in Prime Minister’s questions a few weeks ago, at 47 I had a heart attack. It happened back in August last year, but I must admit that it took several months for me to feel comfortable talking about it more publicly—although I knew that I was on the path to full recovery, and I feel that I am now recovered. As I said in Prime Minister’s questions, I feel a bit thinner for it—that is the physical response. One thing that came through, beyond the fantastic support of the NHS, to which I will refer later, friends and family and my team, was the support of the British Heart Foundation. Its online resources, support and guidance were invaluable in helping me when I was on my own, to find a way through this, get on the path to recovery and understand the stories of others.
I hope the debate will not just share my story—this is not about me—but raise awareness of the early signs and symptoms and some areas of prevention, as well as raising with the Minister, on behalf of others who were perhaps not as fortunate as I was, some of the challenges to early identification of risks. I will aim to cover as much as I can, but I know that others will want to speak, so I will not hog the short time we have. I hope that even one person might come away from watching this debate— I am sure there are millions at home following this debate this afternoon—able to spot a sign for themselves or for a family member or friend, which might save or change their lives.
To start, let us talk about the symptoms. I appreciate that symptoms differ slightly for everybody, and the British Heart Foundation has excellent examples and guidance for what they might be. For me, it started with feeling a sort of numbness and tingling sensation in my left arm and an increasing tightness in my chest, which, as it grew, started to filter to the back of my body. It was not immediate. One often thinks of a heart attack as a cardiac arrest, which is where the heart literally stops and one needs a defibrillator or CPR, but a heart attack can feel more like a slow process that happens quite quickly, if that makes sense.
Even though many years ago, I worked on campaigns to talk about these symptoms with the British Heart Foundation as a client of mine, and even though I knew instinctively what was happening to me, as I started to get those symptoms, even I thought, “I don’t want to phone 999. I don’t want to waste their time.” I ended up calling 111, expecting to hear, “Don’t be silly; take a pill. Go to your GP tomorrow and they’ll get you sorted out.” But they did not say that. The message I had back immediately was that an ambulance was on its way, at which point, I thought, “This might be a bit serious”—but even then I was still in a little denial about the situation.
I will not tell the full story, but I was transferred very quickly to Watford General Hospital, where I was seen and given exemplary care. The East of England Ambulance Service was absolutely incredible with its speed and the compassion and support I was given—the same was true at Watford General, a hospital I love dearly. I was then transferred to Harefield Hospital, where I was again seen very quickly. During that process, I realised the enormity of the situation I was in and the potential that I could lose my life, although I was then unlikely to because I was in the right place at the right time.
The hon. Gentleman mentioned the work of Harefield Hospital. My son has been at Harefield for four months after having a heart transplant just before Christmas; it has been a very traumatic time. I would like to place on record the incredible support and care the hospital provides. I also want to say that we think of heart attacks, heart failure and similar conditions as affecting people my age—maybe people a bit younger or a bit older—but heart failure and heart conditions can affect young people as well. We must not have lazy diagnoses where people think just because somebody is young, they cannot possibly have heart issues, cancer or other issues. As I said, I really want to put on record the great support that Harefield Hospital provides.
May I send my best wishes to the right hon. Gentleman’s son? From my experience, his son is in absolutely the right place, and I hope he has a swift recovery. I echo the right hon. Gentleman’s comments—the staff at Harefield were exemplary at every stage of the process.
Again, I put on record—for my own benefit, rather selfishly—my gratitude to the East of England Ambulance Service, Watford General Hospital and Harefield Hospital, but also the cardiac rehabilitation teams. The experience of being in hospital and having a heart attack was a matter of days, but that of the rehabilitation, exercise programmes and diet changes—all the things that are so important—was a matter of months. I can talk about it not so much as having saved my life, but it has changed my life. I cannot say that I am pleased that it happened, but I am pleased that it happened the way it did, if that makes sense, in making a difference.
I recognise that my experience is not unique, however lucky I am in the experience I have had and the subsequent opportunity to use the platform of Parliament to raise awareness of these conditions and the work of the British Heart Foundation and the NHS. It just felt very apt to have this debate this month because it is World Heart Month. Back-Bench debates are an opportunity to have these conversations and to raise concerns.
Cardiovascular diseases include conditions that affect the heart and circulation, including high blood pressure, stroke and vascular dementia, which I will refer to collectively in the debate as CVD. Over the past six decades, huge strides have been made in improving outcomes for those affected by CVD, with the annual number of deaths falling by around half since the 1960s in part thanks to decades of medical and scientific breakthroughs. That is why research is just so essential.
Today, more than 7 million people are living with heart and circulatory diseases in the UK, and they cause more than a quarter of all UK deaths. In 2022 alone, over 39,000 people in England died prematurely of cardiovascular conditions. That is, on average, 750 people a week. Just to provide a sense of scale, that would fill the Chamber two times over. Despite the premature death rate for CVD continuing to fall by 11% between 2012 and 2019, sadly it remains one of the UK’s biggest killers. The British Heart Foundation is doing a lot of work to raise awareness of waiting lists going up for heart tests and treatment. We need to ensure that we tackle that head on. There is no room for manoeuvre on this. Let us keep moving forward to make a difference.
Order. It will be obvious to the House that we have very little time this afternoon, so I hope that Members will limit their remarks to around five minutes.
I appreciate the point that the hon. Gentleman is making, but there is nothing I can do about it now. Don’t we all sometimes wish that we could turn back the clock? I do not have that power.
I thank the hon. Member for Watford (Dean Russell) for securing this important debate, and for sharing his personal experience of suffering a heart attack. I am delighted to see that he has made such a strong recovery that he can be here in the Chamber today. I am sure that many Members have been affected by cardiac disease, or know people close to them who have been deeply affected by this appalling and shocking killer.
The Library briefing pack for this debate contains a startling statistic. Almost casually, it mentions that cardiovascular deaths per 100,000 population have risen by 10% since 2019, after falling steadily for decades.
Order. I apologise for interrupting the hon. Gentleman, but I have taken what he has just said to heart. I have done my best to squeeze out more time, and he can have around seven minutes.
Thank you, Madam Deputy Speaker. That is a 40% increase. Ask and ye shall receive.
The previous steady reductions followed major improvements in public health policy, reductions in risk factors such as smoking, and the controlling of blood pressure, as well as improvements in medical care. Although I am grateful to the hon. Member for Watford for securing this debate, and to the other Members who will contribute, there is an elephant in the room—indeed, there are so few speakers that there is probably room for a herd of elephants. Why has there been a significant uptick in cardiac deaths in recent years? What novel intervention in public health has occurred since 2019?
Some might think that covid is the cause. Not so. The same uptick in cardiac deaths was observable in Australia and Singapore before those countries got covid but after they rolled out the experimental messenger ribonucleic acid injection. Ah, the jab! I can see some Members tutting and turning away. Everyone knows that MPs with a science degree are few and far between, and that some Members’ eyes glaze over when science is discussed. Well, I am one of those MPs fortunate enough to have a science degree. Another was Margaret Thatcher, who was rather prouder of being the first Prime Minister with a science degree than of being the first woman Prime Minister, and rightly so.
Some Members appear to have prejudged the issue. It is often said that it is easier to fool someone than to persuade them that they have been fooled. For posterity, we must remember that it was 11 years after the thalidomide scandal was exposed in 1961 before the word “thalidomide” was mentioned in the Chamber. I refuse to let this new mammoth medical scandal be ignored in the same way.
We are witnesses to the greatest medical scandal in decades—perhaps in living memory, and possibly ever. It is bigger than thalidomide and bigger than the Tuskegee untreated syphilis scandal, in which some black people were deliberately not treated to see what would happen to their bodies over time. It might be bigger than the Vioxx scandal, hitherto the grandaddy of medical scandals.
Does the hon. Member share my hope that the Minister, in responding to the debate, will address the article in The Daily Sceptic on 20 February this year by Will Jones, headlined “Covid Vaccines Linked to Large Increase in Heart, Blood and Neurological Disorders, Major Study Finds”?
I hope that the Minister will address that, and of course this will go on. Cardiac deaths were already the biggest killer in our country, but we have a mysterious 10% increase. I am sure that the hon. Gentleman, like others in the Chamber, has witnessed the horrifying sight of super-fit athletes keeling over on pitches around the world. A mountain of peer-reviewed evidence is emerging and hypotheses are being proposed. Numerous cardiologists have concerns, but unfortunately, many experts do not feel able to speak out openly about their concerns because of the climate of fear, and the consequences of whistleblowing or speaking out against big pharma, which has so often been found to be not operating in the public interest, and causing harm. I am afraid that we will see much the same, following the roll-out of the covid-19 vaccines, as we saw with Vioxx and thalidomide, and in so many other cases.
The evidence is mounting up so rapidly, and the only people who cannot appreciate what is going on in this country are those who really do not want to see. The public will be extremely harsh on this Parliament and our response to the covid-19 pandemic, including the roll-out of the vaccines. We were going to stop vaccinating after the over-70s, but we then decided that vaccination would include the over-50s. We then decided it would be for everyone. Then this House took the appalling decision, unsupported by the Joint Committee on Vaccination and Immunisation, in September 2021 to vaccinate children who were at very little risk, if any, of covid, but who have been harmed seriously by the vaccines.
Why ever did we use a systemic vaccine for a mucosal respiratory virus? One expert said last year:
“it is not surprising that none of the predominantly mucosal respiratory viruses have ever been effectively controlled by vaccines. This observation raises a question of fundamental importance: if natural mucosal respiratory virus infections do not elicit complete and long-term protective immunity against reinfection, how can we expect vaccines”
It is a pleasure to follow the hon. Member for North West Leicestershire (Andrew Bridgen), as I often seem to in these debates, which often resemble Madame Tussauds: the same faces appear, time after time. As you will know, Madam Deputy Speaker, I have a reputation for brevity in my speeches, and I intend to support that reputation now.
I congratulate my hon. Friend the Member for Watford (Dean Russell) on securing this important and rather timely debate, and I echo the hon. Member for North West Leicestershire in saying that we enjoy seeing him looking so fit and healthy after the trauma that he had. This is a really important matter, and he is right to raise it today. As I highlighted in last month’s Westminster Hall debate on excess death trends, a recent article in The Lancet found that although the causes of ongoing excess deaths in the UK
“are likely to be multiple”,
Office for National Statistics data showed some clear trends—in particular, the “largest relative excess deaths” since the pandemic occurred in young and middle-aged adults, with the number of cardiac deaths happening outside hospitals being the most elevated. In other words, young and previously healthy people are dying at home from cardiac-related events, and we do not know why.
These are not just numbers and statistics—these are real people, loved ones, often from younger age groups, who are dying before their time. It is urgent and our duty to get to the bottom of the situation sooner rather than later. As I am sure we are all aware, there are many theories circulating about the causes of these excess deaths. One is the possibility of a causal link between the population-wide use of covid-19 vaccines and the marked increase in cardiovascular-related critical events, including heart attacks and strokes, among otherwise apparently healthy people. We do not know if that is the cause or not, because the data is not being released. Until certain data sets are released, it is impossible to rule that theory in or out.
20 of 37 shown
More analysis is needed. From lifesaving research by the British Heart Foundation, we know that the causes of premature deaths from CVD are multifaceted and complex. The NHS long-term care plan intends to look at many of those areas, but I call on the Government to be bold and consider co-ordinated action to address the issue in three ways. I urge them to prioritise heart care within the NHS to accelerate vital care; to ensure better protection from heart disease by addressing the drivers and underlying health conditions, such as obesity and smoking; and finally, to create a research and development ecosystem for breakthroughs, treatments and cures.
I welcome the significant work already under way through the Government’s major conditions strategy and the inclusion of cardiovascular disease in it. The interim report, published last summer by the Department of Health and Social Care, made clear the scale and urgency of the Government’s priority to address this issue. Urgency is absolutely key here. Around 80% of cases of CVD are attributed to modifiable risk factors such as high blood pressure, obesity, poor diet and smoking, making CVD largely preventable through a number of lifestyle choices.
Politically, I am not one who thinks that the state should intervene and stop people from being able to enjoy their lives, but I think education is key. Education can come through many different means, including engagement with the NHS and GPs providing advice. It is not about the state stopping people making lifestyle choices, but it is fair enough to let them know what those lifestyle choices might lead to, and what can make a big difference to them and their family.
Nearly two thirds of adults in the UK, around 64%, are overweight or living with obesity. Up to 8 million people have either undiagnosed or uncontrolled high blood pressure. From my own personal experience, I admit that I knew I was not going to be running in the Olympics any time soon—I cannot exactly describe myself as an Adonis—but while I knew I was slightly overweight, I thought I would be okay. I thought that these things do not happen to somebody at the age of 47. Like most of us, I thought these things happen to somebody else. That is the way our minds work. This was a wake-up call for me, and that is why I want to make a wake-up call to others from this wonderful platform of the House of Commons Chamber. Do not assume that it is all okay. Get checked out and make sure that you watch out for the signs.
I therefore welcome the Government’s ambition to halve childhood obesity by 2030, and to help adults reach a healthier weight through a range of preventive measures to empower people to take control of their own health. Of course, everyone has different ways of doing that. I will not share my own dietary habits, because I am sure that some dietician will watch this and tell me I have got it totally wrong, but I have lost about 2 stone in the past four or five months. I did not do it by fasting—I know the Prime Minister does his fast each week, so I will not comment on that—or by adopting a fad diet; I simply made some small changes in my lifestyle and the way I live my life.
Like many people, we as Members of Parliament work long hours. My father was a lorry driver, and I am proud of the long hours he worked and the work that he did to bring me up. Our job here is not particularly physical, but it does involve long hours and is quite sedentary at times, and the same probably applies to the jobs of a great many people throughout the UK. Being mindful of that, and going for a walk and getting a bit of exercise, can make a big difference.
The NHS long-term plan sets out the Government’s determination to prevent 150,000 heart attacks, strokes and dementia cases over the course of 10 years. I welcome the focus on early intervention to help people live longer, healthier lives, but we all know that smoking is still the single leading behavioural cause of preventable death in this country. I very much support the Government’s desire for a smoke-free generation by 2030, and I am glad they are pressing on with a tobacco and vapes Bill to ensure that children who are now 14 or younger—that is, anyone born on or after 1 April 2009—can never legally be sold tobacco products.
Addressing lifestyle concerns and identifying underlying conditions earlier could help to prevent tens of thousands of heart attacks and strokes, and could support the Government’s ambition to increase healthy life expectancy by five years by 2035, but I think it means more than that. To me, it means that a child will grow up seeing their father or their mother. It means that friends and families can see a loved one reach the age at which they can call that person a grandparent, or that person can see them graduate. This, for me, is not just about Government policy; it is about the impact on real people who can be helped to lead a positive life.
When we talk about heart attacks, heart disease and the other issues we are discussing today, we are of course talking about premature deaths, but for most people who are affected those conditions constitute a restriction on their lives, and I want to ensure that we improve that situation for everyone in the country. I am proud to say that the UK continues to lead the way in medical research, establishing innovative methods of early diagnosis and effective treatment.
As many Members will know, I campaigned vigorously with West Hertfordshire Teaching Hospitals NHS Trust to secure the necessary funding for the new hospital in Watford, and it was a proud and important moment when we did. One reason I supported that so strongly was the incredible work I saw being done at Watford General Hospital, especially in relation to the virtual hospital programme. It has led the way in showing that there are other ways of supporting people’s health, particularly at home, and adopting the idea of using technology and data to help improve people’s lifestyles. The beauty of the modern age is that many apps can give people guidance on their health. They have Apple watches or Fitbits or whatever else is out there; I do not want to go down the route of one particular brand. We are now able to track so much more of our health, but I think we need more education on what that data means. We can all see our heart rates, but what is the actual impact on people’s lives?
Virtual care is important in this regard, but—I will not go too far down this route, Madam Deputy Speaker, because I think it is for a different debate—I have long argued for what I call data donation. At present someone who sadly loses their life may donate an organ, but if we could donate our lifestyle data throughout our lives, the NHS and other organisations could start asking themselves whether they could, for instance, cure cancer by using that data, which would be anonymised, with all the necessary checks and balances to ensure that it was done well.
I am conscious of the time, and I am sure that I am going over my allocated period, but I want to highlight the fact that despite all the developments, CVD continues to have an impact on the wider economy, costing an estimated £21 billion annually in England alone. As I say, behind every figure is a person or a family who have been deeply affected by these conditions. As part of this process, I was fortunate to work with the House of Commons Chamber engagement team, who reached out to constituents across the country to share their own experiences in preparation for this debate. I believe that the correspondence should be in the Library; if not, I will make sure that it is shared with colleagues and put online. One respondent really moved me. They said that their daughter
“has half a working heart; she’s had two open heart surgeries and will need another. If it hadn’t been detected early, she wouldn’t be with us today.”
That is a life, an ambition and a future that is still there because of the support that has been given.
I know that I am doing a bit of a plug for the British Heart Foundation today, but one of the other comments, which rings true with my experience, was that the
“British Heart Foundation has a brilliant website for facts, and the consultant team we are under at our local hospital are fantastic.”
There were many quotes from people sharing very similar stories. A common concern, though, was about aftercare following surgery or medical treatment and the effects that people’s conditions have had on them mentally and socially. From my own experience, I have to admit that I suddenly started to feel twinges all the time and think, “Is there something wrong with me? Is it happening again?”
My experience is that within two weeks of having a heart attack, I promised that I would go to a local event; I did not want to let people down. I remember going to it on a searing hot day. I was genuinely frightened about going out in the heat with people and not knowing whether my body would still work in the way I hoped it would. I am glad I did it, because once I had gone through the experience of being there and realising that I could still be me, I was able to overcome that and continue to work as safely and as best I could as I recovered.
However, not everybody gets that opportunity. When someone has had a physical illness, particularly when it affects the heart, it is easy for them to suddenly worry that they do not have control over themselves, and they do not know what might happen next. I must admit that there have been many times when something has twinged and I have thought, “Is this a heart attack again?” Thankfully, it has not been, but aftercare is absolutely essential. We can fix the body, but helping to support the mind through that psychological process is absolutely essential. I know that colleagues in the House will have far more powerful stories about their experiences than mine, and I look forward to hearing them later.
This is about multidisciplinary care that does not end when the patient leaves the hospital. It is about supporting their full recovery and helping them with some lifestyle changes. I have to admit that the cardiac rehabilitation team I worked with were phenomenal. When I was extremely concerned, they would put my mind at rest, which meant that I was better physically and mentally. I therefore ask the Minister whether consideration will be given to offering counselling services and mental health support to those affected by heart and circulatory conditions.
As I have said, heart and circulatory diseases cause a quarter of all deaths in England, amounting to over 140,000 each year, 480 a day or one every three minutes. Sadly, in the time that I have spoken today, five people will have lost their lives. I therefore call for urgent action to do more to protect our hearts. By prioritising the right action and supercharging the progress that has been made on addressing heart and circulatory diseases, we can improve the nation’s health, grow the economy and give people hope for a brighter, healthier future.
I can see some Members looking puzzled. Vioxx was a new drug invented by Merck as an alternative to aspirin—a mild painkiller. A researcher first highlighted an issue to Merck’s senior management in 1997, two years before the drug was approved. One in 115 people who took Vioxx suffered a heart attack. Merck’s profits from Vioxx comfortably exceeded the criminal fine, the compensation and the litigation costs after the drug was pulled. It was a good business decision for Merck. Not one pharma executive went to jail for skewing the trial results, for deceiving the regulators or for recklessly causing the deaths of 60,000 ordinary Americans for profit. It is always for profit—lives tragically cut short, families destroyed and children devastated. Imagine the incentive structure in an industry where profits like that can be made, and the corporate greed where there is full immunity from prosecution. In 1986, pharma companies got immunity in the USA for all vaccines. The number of vaccines administered to children in America has exploded since then.
to work, when natural immunity does not give protection? And what is the name of this expert? Mr Anthony Fauci, the former head of the Centres for Disease Control and Prevention in America, who pushed the vaccines.
I wish I had more time, Madam Deputy Speaker; this is a huge issue and we need to debate it again. It is the biggest killer of our constituents, and our fear is that the rate of increase in cardiac deaths will not slow in the UK, or the rest of the world.
That is why I, along with cross-party colleagues, wrote yesterday to the Secretary of State for Health and Social Care; Professor Steven Riley, the director general for data at the UK Health Security Agency; and Dr Alison Cave, the chief safety officer at the Medicines and Healthcare Products Regulatory Agency. We warn that by withholding official data, the Department, UKHSA and MHRA are helping fuel concerns and hesitancy about public health. We have asked that anonymised record-level official mortality data be released, alongside vaccination dates, doses and co-morbidities, without delay. We understand that the MHRA has collected and already shared this data with pharmaceutical companies to enable those companies to produce post-authorisation safety studies for their products, so I see no reason why it cannot also be shared with parliamentarians and the public right away. Will the Minister say whether that data has been shared with pharmaceutical companies? If so, why is not being shared with the rest of us?
As the Minister surely realises, repetitive generic assurances that the Government and the UKHSA take excess deaths “seriously” and monitor them “constantly”, and that the MHRA have
“systems in place to continually monitor the safety of our medicines”—[Official Report, 16 January 2024; Vol. 743, c. 235WH.]
do not serve to reassure anybody at all. Likewise, the news from the Office for National Statistics this week that it has revised its excess deaths methodology, and that there are suddenly 20,000 fewer excess deaths last year, has done little to quell public concern. If anything, it has done the exact opposite: people cynically see it as a convenient sleight of hand.
As we say in our letter, if the Government and their agencies are not willing to share the data we have requested, will the Minister explain to us why not? We are all on the same side and want to look after people. We are all concerned to do the best we can for everybody, but until we have all the data, we just do not know what we do not know. If there is any potential that public health interventions, such as covid-19 vaccines, are causing harm and premature death to some, we must act on that without delay. If the evidence shows that that there is no issue, then it is in everybody’s interest for that reassurance to be in the public domain as quickly as possible.